These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17621956)

  • 1. Topical vaccination: the skin as a unique portal to adaptive immune responses.
    Huang CM
    Semin Immunopathol; 2007 Apr; 29(1):71-80. PubMed ID: 17621956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant sodium lauryl sulfate enhances skin vaccination: molecular characterization via a novel technique using ultrafiltration capillaries and mass spectrometric proteomics.
    Huang CM; Wang CC; Kawai M; Barnes S; Elmets CA
    Mol Cell Proteomics; 2006 Mar; 5(3):523-32. PubMed ID: 16316979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination.
    Himes R; Lee S; McMenigall K; Russell-Jones G
    Vaccine; 2011 Jul; 29(33):5393-8. PubMed ID: 21664219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol.
    Kim YC; Park JH; Ludovice PJ; Prausnitz MR
    Int J Pharm; 2008 Mar; 352(1-2):129-38. PubMed ID: 18079075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticulate mediated transcutaneous immunization: Myth or reality.
    Kaurav M; Minz S; Sahu K; Kumar M; Madan J; Pandey RS
    Nanomedicine; 2016 May; 12(4):1063-1081. PubMed ID: 26767517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for cutaneous vaccine delivery.
    Hirschberg HJ; van Riet E; Oosterhoff D; Bouwstra JA; Kersten GF
    Eur J Pharm Sci; 2015 Apr; 71():112-22. PubMed ID: 25686596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing tumor specific immune responses by transcutaneous vaccination.
    Saliba H; Heurtault B; Bouharoun-Tayoun H; Flacher V; Frisch B; Fournel S; Chamat S
    Expert Rev Vaccines; 2017 Nov; 16(11):1079-1094. PubMed ID: 28937293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactants have multi-fold effects on skin barrier function.
    Lemery E; Briançon S; Chevalier Y; Oddos T; Gohier A; Boyron O; Bolzinger MA
    Eur J Dermatol; 2015; 25(5):424-35. PubMed ID: 26109150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel serine-based gemini surfactants as chemical permeation enhancers of local anesthetics: A comprehensive study on structure-activity relationships, molecular dynamics and dermal delivery.
    Teixeira RS; Cova TF; Silva SM; Oliveira R; do Vale ML; Marques EF; Pais AA; Veiga FJ
    Eur J Pharm Biopharm; 2015 Jun; 93():205-13. PubMed ID: 25748796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water disrupts stratum corneum lipid lamellae: damage is similar to surfactants.
    Warner RR; Boissy YL; Lilly NA; Spears MJ; McKillop K; Marshall JL; Stone KJ
    J Invest Dermatol; 1999 Dec; 113(6):960-6. PubMed ID: 10594737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery enhanced by antimicrobial peptides.
    Kim YC; Ludovice PJ; Prausnitz MR
    J Biomed Nanotechnol; 2010 Oct; 6(5):612-20. PubMed ID: 21329054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organization of stratum corneum lipids in relation to permeability: influence of sodium lauryl sulfate and preheating.
    Ribaud C; Garson JC; Doucet J; Lévêque JL
    Pharm Res; 1994 Oct; 11(10):1414-8. PubMed ID: 7855044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive enhancement strategies in topical and transdermal drug delivery.
    Hadgraft J
    Int J Pharm; 1999 Jul; 184(1):1-6. PubMed ID: 10425346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of excipients for topical preparations on the human skin permeability of terpinen-4-ol contained in Tea tree oil: infrared spectroscopic investigations.
    Casiraghi A; Minghetti P; Cilurzo F; Selmin F; Gambaro V; Montanari L
    Pharm Dev Technol; 2010; 15(5):545-52. PubMed ID: 19842911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial ablation of porcine stratum corneum by argon-fluoride excimer laser to enhance transdermal drug permeability.
    Fujiwara A; Hinokitani T; Goto K; Arai T
    Lasers Med Sci; 2005; 19(4):210-7. PubMed ID: 15609006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.